Actelion AC 058B302: Multicenter, randomized, double-blind, parallel-group, add-on, superiority study to compare the efficacy and safety of ponesimod to placebo in subjects with active relapsing multiple sclerosis who are treated with dimethyl fumarate (Tecfidera)

July 26, 2018
Multiple Sclerosis
Principal Investigator: Mirela Cerghet, MD
MS, Multiple Sclerosis, RMS, Relapsing Multiple Sclerosis
Accepting Participants